 MALVERN, Pa., Nov. 02, 2020 GLOBE NEWSWIRE -- Neuronetics, Inc. NASDAQ: STIM, a commercial stage medical technology company focused on designing, developing and marketing products that improve the quality of life for patients who suffer from psychiatric disorders, today announced its financial and operating results for the third quarter of 2020. 